Non-Dopaminergic Therapies

Currently all aspects of Parkinson’s disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS n...

Descripción completa

Detalles Bibliográficos
Autores principales: Nutt, John G., Bohnen, Nicolaas I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311374/
https://www.ncbi.nlm.nih.gov/pubmed/30584157
http://dx.doi.org/10.3233/JPD-181472
Descripción
Sumario:Currently all aspects of Parkinson’s disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS non-PD co-pathologies or co-morbidities that may exacerbate progression of various aspects of PD.

Ejemplares similares